Larry N Agbor

793 total citations
22 papers, 575 citations indexed

About

Larry N Agbor is a scholar working on Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, Larry N Agbor has authored 22 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biochemistry, 9 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Larry N Agbor's work include Eicosanoids and Hypertension Pharmacology (10 papers), Nitric Oxide and Endothelin Effects (7 papers) and Hormonal Regulation and Hypertension (6 papers). Larry N Agbor is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (10 papers), Nitric Oxide and Endothelin Effects (7 papers) and Hormonal Regulation and Hypertension (6 papers). Larry N Agbor collaborates with scholars based in United States, Germany and China. Larry N Agbor's co-authors include Curt D. Sigmund, Mary Walker, Frederick W. Quelle, Stella‐Rita Ibeawuchi, Khalid M. Elased, Jing Wu, Anand R. Nair, Jeffrey D. Singer, Chunyan Hu and Mary T. Walsh and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The FASEB Journal.

In The Last Decade

Larry N Agbor

22 papers receiving 573 citations

Peers

Larry N Agbor
Karim Benkirane Canada
Zsuzsanna Ament United States
Anna Ljungberg Sweden
Carlos Bocos Spain
Saadet Türkseven Türkiye
Déborah Vallée France
H Wehr Poland
Samantha L. Hoopes United States
Frank Fan Zhang United States
Stefanie Bittner United States
Karim Benkirane Canada
Larry N Agbor
Citations per year, relative to Larry N Agbor Larry N Agbor (= 1×) peers Karim Benkirane

Countries citing papers authored by Larry N Agbor

Since Specialization
Citations

This map shows the geographic impact of Larry N Agbor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry N Agbor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry N Agbor more than expected).

Fields of papers citing papers by Larry N Agbor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry N Agbor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry N Agbor. The network helps show where Larry N Agbor may publish in the future.

Co-authorship network of co-authors of Larry N Agbor

This figure shows the co-authorship network connecting the top 25 collaborators of Larry N Agbor. A scholar is included among the top collaborators of Larry N Agbor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry N Agbor. Larry N Agbor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Jing, Shi Fang, Gaurav Kumar, et al.. (2022). Endothelial Cullin3 Mutation Impairs Nitric Oxide-Mediated Vasodilation and Promotes Salt-Induced Hypertension. Function. 3(3). zqac017–zqac017. 11 indexed citations
2.
Nair, Anand R., Larry N Agbor, Javier A. Gomez, et al.. (2020). Increased Susceptibility of Mice Lacking Renin-b to Angiotensin II–Induced Organ Damage. Hypertension. 76(2). 468–477. 9 indexed citations
3.
Agbor, Larry N, Anand R. Nair, Jing Wu, et al.. (2019). Conditional deletion of smooth muscle Cullin-3 causes severe progressive hypertension. JCI Insight. 4(14). 25 indexed citations
4.
Mukohda, Masashi, Shi Fang, Jing Wu, et al.. (2019). RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activity. Journal of Clinical Investigation. 129(6). 2318–2332. 33 indexed citations
5.
6.
Agbor, Larry N, et al.. (2019). Cul3 regulates cyclin E1 protein abundance via a degron located within the N-terminal region of cyclin E. Journal of Cell Science. 132(21). 14 indexed citations
7.
Cornelius, Ryan J., Chong Zhang, Kayla J. Erspamer, et al.. (2018). Dual gain and loss of cullin 3 function mediates familial hyperkalemic hypertension. American Journal of Physiology-Renal Physiology. 315(4). F1006–F1018. 17 indexed citations
8.
9.
Ferdaus, Mohammed Z., Lauren N. Miller, Larry N Agbor, et al.. (2017). Mutant Cullin 3 causes familial hyperkalemic hypertension via dominant effects. JCI Insight. 2(24). 43 indexed citations
10.
Nair, Anand R., Larry N Agbor, Masashi Mukohda, et al.. (2017). Interference with PPARγ in the Endothelium Causes Cerebral Vascular Dysfunction in Response to Endogenous Renin‐Angiotensin System Activation. The FASEB Journal. 31(S1). 1 indexed citations
11.
Agbor, Larry N, Anand R. Nair, Jing Wu, et al.. (2017). Smooth Muscle‐Specific Deletion of Cullin‐3 Causes Severe Early Onset Hypertension. The FASEB Journal. 31(S1). 1 indexed citations
12.
Agbor, Larry N, Stella‐Rita Ibeawuchi, Chunyan Hu, et al.. (2016). Cullin-3 mutation causes arterial stiffness and hypertension through a vascular smooth muscle mechanism. JCI Insight. 1(19). e91015–e91015. 53 indexed citations
13.
Ibeawuchi, Stella‐Rita, Larry N Agbor, Frederick W. Quelle, & Curt D. Sigmund. (2015). Hypertension-causing Mutations in Cullin3 Protein Impair RhoA Protein Ubiquitination and Augment the Association with Substrate Adaptors. Journal of Biological Chemistry. 290(31). 19208–19217. 53 indexed citations
14.
Agbor, Larry N, et al.. (2014). Role of CYP1A1 in Modulating the Vascular and Blood Pressure Benefits of Omega-3 Polyunsaturated Fatty Acids. Journal of Pharmacology and Experimental Therapeutics. 351(3). 688–698. 17 indexed citations
15.
Agbor, Larry N, et al.. (2013). New point mutation in Golga3 causes multiple defects in spermatogenesis. Andrology. 1(3). 440–450. 21 indexed citations
16.
Agbor, Larry N, et al.. (2012). Elevated blood pressure in cytochrome P4501A1 knockout mice is associated with reduced vasodilation to omega − 3 polyunsaturated fatty acids. Toxicology and Applied Pharmacology. 264(3). 351–360. 45 indexed citations
17.
Agbor, Larry N, Khalid M. Elased, & Mary Walker. (2011). Endothelial cell-specific aryl hydrocarbon receptor knockout mice exhibit hypotension mediated, in part, by an attenuated angiotensin II responsiveness. Biochemical Pharmacology. 82(5). 514–523. 31 indexed citations
18.
Kopf, Phillip G., Jason A. Scott, Larry N Agbor, et al.. (2010). Cytochrome P4501A1 Is Required for Vascular Dysfunction and Hypertension Induced by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin. Toxicological Sciences. 117(2). 537–546. 61 indexed citations
19.
Zhang, Nan, Larry N Agbor, Jason A. Scott, et al.. (2010). An activated renin–angiotensin system maintains normal blood pressure in aryl hydrocarbon receptor heterozygous mice but not in null mice. Biochemical Pharmacology. 80(2). 197–204. 29 indexed citations
20.
Lund, Amie K., Larry N Agbor, Nan Zhang, et al.. (2008). Loss of the Aryl Hydrocarbon Receptor Induces Hypoxemia, Endothelin-1, and Systemic Hypertension at Modest Altitude. Hypertension. 51(3). 803–809. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karim Benkirane Breakdown of academic impact, for papers by Zsuzsanna Ament Breakdown of academic impact, for papers by Anna Ljungberg Breakdown of academic impact, for papers by Carlos Bocos Breakdown of academic impact, for papers by Saadet Türkseven Breakdown of academic impact, for papers by Déborah Vallée Breakdown of academic impact, for papers by H Wehr Breakdown of academic impact, for papers by Samantha L. Hoopes Breakdown of academic impact, for papers by Frank Fan Zhang Breakdown of academic impact, for papers by Stefanie Bittner
Rankless by CCL
2026